News about "Peptide Manufacturing"

Neuland Accelerates Peptide Manufacturing Expansion

Neuland Accelerates Peptide Manufacturing Expansion

Neuland expands peptide manufacturing capacity as its first commercial peptide module becomes operational, with further expansion underway to meet rising customer demand.

Peptide Manufacturing | 15/09/2026 | By News Bureau |  114

HRV Pharma Invests INR 150 Crore to Expand Peptide and High-Potent API Capabilities

HRV Pharma Invests INR 150 Crore to Expand Peptide and High-Potent API Capabilities

HRV Pharma invests INR 150 crore to expand peptide and high-potent Active Pharmaceutical Ingredient (API) capabilities, strengthening its position in high-value pharmaceutical segments.

Peptide Manufacturing | 08/09/2026 | By News Bureau |  130

Piramal Pharma Solutions Expands Peptide API Manufacturing with Advanced Spray Drying

Piramal Pharma Solutions Expands Peptide API Manufacturing with Advanced Spray Drying

Piramal Pharma Solutions has added a new spray drying suite with Band 5 containment capacity at its dedicated peptide facility in Turbhe, India, equipped with its own air handling units, nitrogen supply, and control systems. It empowers Turbhe to support the formulation of challenging molecules, including peptides, HPAPIs, and other biomolecules.

Peptide Manufacturing | 04/08/2026 | By News Bureau |  189

Beyond the GLP-1 Boom...

Beyond the GLP-1 Boom...

The rise of GLP-1 therapies has transformed diabetes and obesity treatment. Following semaglutide patent expiry in India in March 2026, multiple companies entered the market simultaneously. Pharma Industrial India spoke with industry leaders about the opportunities, challenges, and future of this rapidly evolving therapeutic segment.

Peptide Manufacturing | 26/06/2026 | By Akanki |  174

Neuland Laboratories Partners with LIR Life Sciences Corp to Advance Transdermal GLP-1 Obesity Therapy

Neuland Laboratories Partners with LIR Life Sciences Corp to Advance Transdermal GLP-1 Obesity Therapy

Neuland Laboratories partnership with LIR Life Sciences Corp will focus on developing and manufacturing cell-penetrating peptides to support LIR Life’s patch-based GLP-1/GIP obesity treatment platform.

Peptide Manufacturing | 07/05/2026 | By News Bureau |  268

WuXi STA adds peptide manufacturing capacity at Changzhou campus

WuXi STA adds peptide manufacturing capacity at Changzhou campus

With two new 2,000L reactors the total reactor volume of the Solid Phase Peptide Synthesizers at WuXi TIDES has increased to over 10,000 litres

Peptide Manufacturing | 08/05/2023 | By Sudeep Soparkar |  1015


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members